# Mefenamic_acid-Dapagliflozin-DDI
Modeling of published clinical Mefenamic acid-Dapagliflozin-DDI studies for model evaluation.

The repository contains a PK-Sim snapshot (*.json) file containing the respective simulations.

**The latest release of the snapshot can be found [here](../../releases/latest).**

The reference model repositories can be found here:

- Mefenamic acid [[1](#reference)]
- Dapagliflozin [[2](#reference)]

## Code of conduct

Everyone interacting in the Open Systems Pharmacology community (codebases, issue trackers, chat rooms, mailing lists etc...) is expected to follow the Open Systems Pharmacology [code of conduct](https://github.com/Open-Systems-Pharmacology/Suite/blob/master/CODE_OF_CONDUCT.md#contributor-covenant-code-of-conduct).

## Contribution

We encourage contribution to the Open Systems Pharmacology community. Before getting started please read the [contribution guidelines](https://github.com/Open-Systems-Pharmacology/Suite/blob/master/CONTRIBUTING.md#ways-to-contribute). If you are contributing code, please be familiar with the [coding standard](https://github.com/Open-Systems-Pharmacology/Suite/blob/master/CODING_STANDARDS.md#visual-studio-settings).

## License

The model code is distributed under the [GPLv2 License](https://github.com/Open-Systems-Pharmacology/Suite/blob/develop/LICENSE).

## Reference
[1] [Mefenamic acid OSP PBPK model](https://github.com/Open-Systems-Pharmacology/Mefenamic-acid-Model)

[2] [Dapagliflozin OSP PBPK model](https://github.com/Open-Systems-Pharmacology/Dapagliflozin-Model)
